Compound reference
Pinealon is explored for neuronal responses to oxidative stress. Preclinical findings offer a basis for neural-protection research, rather than established cognitive or calming benefits in dogs.
Explore the selected studies, their findings and their limits.
In a rat model of prenatal hyperhomocysteinemia, Pinealon was associated with changes in offspring behavior and resistance of isolated neurons to oxidative stress. The study investigated a specific developmental injury model. It did not test treatment of cognitive decline, anxiety or sleep problems in older dogs.
The studies discussed here do not establish the safety or effectiveness of this catalog formula in dogs. Rat, mouse, cell-culture and human findings are not canine clinical results; they also do not establish absorption or effects from the listed oral formula.
For more information, contact info@aurevixpeptides.com.
Editorial review: September 23, 2026
